Histopathological staging of atrophic lesions of gastric mucosa.

Atrophic lesion Gastric mucosal biopsy Histomorphology Immunohistochemistry Pathological staging

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
30 Mar 2024
Historique:
received: 19 01 2023
revised: 07 03 2024
accepted: 07 03 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: epublish

Résumé

To study the histopathological staging of atrophic lesions of the gastric mucosa. Histology and immunohistochemistry were used to closely examine 2144 specimens of atrophic gastric mucosa that were taken from endoscopic biopsies. When the gastric mucosa epithelium is affected by infection, chemical stimulation, immune factors, genetic factors, and other factors, it may cause an atrophy of gastric mucosa epithelium and a decrease in the number of glands, intestinal metaplasia, hyperplasia of smooth muscle fibers, and atrophy of stem cells in the proliferative zone. In this study, we characterized the above lesions as atrophic lesions of the gastric mucosa. Based on the morphological and histological characteristics of the lesion, as well as the law of cell proliferation and transformation during its occurrence and development, we propose five stages. We also noted the onset age, gender correlation, and histopathological characteristics of each stage of gastric mucosal atrophies. Understanding the pathological staging of gastric mucosal atrophy is essential for treating patients correctly and keeping track of changes in malignant cells. It is also very important in preventing the initiation of gastric cancer or from getting worse.

Identifiants

pubmed: 38560685
doi: 10.1016/j.heliyon.2024.e27845
pii: S2405-8440(24)03876-3
pmc: PMC10979135
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e27845

Informations de copyright

© 2024 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yang-Kun Wang (YK)

The Fourth People"s Hospital of Longgang District, Shenzhen, 518123, China.

Ying-Ying Li (YY)

Shenzhen Polytechnic University, Shenzhen, 518055, China.

Bin Wang (B)

Department of Radiation Therapy, Cancer Center, Shanghai Jiahui International Hospital, Shanghai, 200000, China.

Dong-Mei Ran (DM)

Department of Pathology, Southern University of Science and Technology Hospital, Shenzhen, 518055, China.

Chao-Ya Zhu (CY)

Third Affiliated Hospital of Zhengzhou University, Shenzhen, 450052, China.

Ping Li (P)

Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, 518036, China.

Bo Jiang (B)

Department of Pathology, No. 990 Hospital of the PLA Joint Logistics Support Force, Zhumadian, 463000, China.

Su-Nan Wang (SN)

Shenzhen Polytechnic University, Shenzhen, 518055, China.

Classifications MeSH